Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients

If I remember correctly 25% of the patients they treated in phase 2 with this drug actually entered remission. Seems like this might be the miracle med we’ve all been waiting for.

3 Likes